(VIANEWS) – Genomic Vision (GV.PA) Stock Gains 31.58% in Ten Sessions Despite CAC 40 Decline Genomic Vision (GV.PA) shares have experienced an astonishing turnaround over the last 10 sessions, despite CAC 40 index’s downward movement. On Wednesday alone, Genomic Vision shares surged 31.58% from EUR0.01 to EUR0.01 at 16:07 EST; an astonishing turnaround from its…
(VIANEWS) – GENOMIC VISION (GV.PA) experienced an extraordinary increase of 28.21% over 10 sessions, following three consecutive days of losses. Even as CAC 40 fell by 1.32% overall to EUR7,089.83; its closing price for GENOMIC VISION stood out as significantly below its 52-week high of EUR0.10 and thus representing a substantial decline from its former…
(VIANEWS) – Over the past 10 sessions, shares of GENOMIC VISION (CAC 40: GV.PA) have seen an incredible 25% surge, rising from EUR0.01 to EUR0.01 by 16:07 EST Thursday afternoon – after experiencing two sessions of declines. Meanwhile, CAC 40 was down 1.51% at EUR7,219.83 following two consecutive gains; its last closing price for GENOMIC…
(VIANEWS) – Shares of GENOMIC VISION (GV.PA) on the CAC 40 index experienced a remarkable 26.58% gain over 10 sessions, rising from EUR0.01 to EUR0.01 at 16:07 EST on Wednesday – marking an upswing that follows suit with its previous upward trajectory. Overall, CAC 40 was up 0.68% at EUR7,331.38, continuing its recent upward movement…
(VIANEWS) – Genomic Vision (GV.PA), listed on France’s CAC 40 index, experienced a remarkable surge in its stock prices over just 10 sessions – its shares had increased by 26.58% from EUR0.01 at 16:07 EST on Monday to EUR0.01 by 16:07 EST! This sudden uptick came following five consecutive sessions of losses. Genomic Vision’s impressive…
(VIANEWS) – Genetic Vision (GV.PA) Shares Soar 21.95% in 10 Sessions, Breaking 4-Session Losing Streak Shares of GENOMIC VISION (CAC 40: GV.PA) have experienced an astonishing turnaround over the last 10 sessions, rising 21.95%. After four straight downfalls, shares ended the day up at EUR0.01, pushing the CAC 40 index up 0.9% to EUR7,287.63 and…
(VIANEWS) – Genomic Vision (GV.PA) shares have experienced an exceptional surge, rising 21.95% over the past ten sessions and reaching EUR0.01 on Wednesday during trading – following three consecutive losses on the CAC 40 index. Unfortunately, Genomic Vision’s performance may be affected by its current downtrend of 0.3% at EUR7,231.16, with its last closing price…
(VIANEWS) – Over the past ten sessions, shares of GENOMIC VISION (CAC 40: GV.PA) experienced an unprecedented surge of 21.95%, beginning from EUR0.01 and reaching EUR0.00 at 16:07 EST on Monday afternoon. Following two consecutive gains for CAC 40 index as a whole and 92.73% below its 52-week high of EUR0.11, shares of GENOMIC VISION…
(VIANEWS) – Genomic Vision (GV.PA), a biotech company listed on France’s CAC 40 index, has recently attracted renewed investor attention. Over 10 trading sessions, its shares soared 23.46% – moving from EUR0.01 to EUR0.01, as of 16:08 EST Friday afternoon – following yesterday’s positive performance by both Genomic Vision’s stock price and CAC 40 index…
(VIANEWS) – Genomic Vision (GV.PA) shares experienced an extraordinary surge, rising 20.48% over 10 sessions to reach EUR0.01 on Wednesday at 16:09 EST – following suit with last session’s uptrend – while CAC 40 index shows decrease of 0.76% reaching EUR7,199.79; this marks five consecutive sessions of losses. About GENOMIC VISION Genomic Vision Societe Anonyme…
